- Home
- FPAY vs INM Comparison
FPAY vs INM Comparison
Compare FPAY & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- INM
- Stock Information
- Founded
- FPAY 2003
- INM 1981
- Country
- FPAY United States
- INM Canada
- Employees
- FPAY N/A
- INM N/A
- Industry
- FPAY Diversified Commercial Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- FPAY Consumer Discretionary
- INM Health Care
- Exchange
- FPAY Nasdaq
- INM Nasdaq
- Market Cap
- FPAY 31.0M
- INM 3.2M
- IPO Year
- FPAY N/A
- INM N/A
- Fundamental
- Price
- FPAY $1.37
- INM $2.33
- Analyst Decision
- FPAY Strong Buy
- INM
- Analyst Count
- FPAY 2
- INM 0
- Target Price
- FPAY $3.25
- INM N/A
- AVG Volume (30 Days)
- FPAY 47.1K
- INM 46.6K
- Earning Date
- FPAY 05-20-2025
- INM 05-13-2025
- Dividend Yield
- FPAY N/A
- INM N/A
- EPS Growth
- FPAY N/A
- INM N/A
- EPS
- FPAY N/A
- INM N/A
- Revenue
- FPAY $139,800,732.00
- INM $4,832,013.00
- Revenue This Year
- FPAY $12.05
- INM N/A
- Revenue Next Year
- FPAY N/A
- INM N/A
- P/E Ratio
- FPAY N/A
- INM N/A
- Revenue Growth
- FPAY 19.51
- INM N/A
- 52 Week Low
- FPAY $0.97
- INM $1.72
- 52 Week High
- FPAY $2.37
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- FPAY 53.97
- INM 34.09
- Support Level
- FPAY $1.30
- INM $2.70
- Resistance Level
- FPAY $1.47
- INM $3.20
- Average True Range (ATR)
- FPAY 0.08
- INM 0.23
- MACD
- FPAY 0.01
- INM -0.05
- Stochastic Oscillator
- FPAY 61.76
- INM 5.26
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.